Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by fasttrack5on Jan 10, 2025 6:32pm
44 Views
Post# 36398888

RE:RE:RE:RE:Jp.morgan

RE:RE:RE:RE:Jp.morgan
canadafan wrote: Now that the market is closed I will post , since one not be mentioned feels I have comtrol over 1000s of peoples actions.
Insinuating every time I post the price goes down.Just plain silly. 
Well folks not too far back I posted I was going to buy..recall I said "was going to sleep on it"
The  next day posted that I did buy 30% more sahres. The price went from about $1.20 to $1.40  within a few days.
Perhaps my posting sent it up as well. (LOL)
Out right dillusional , silly comments. 
Not sure of ones motivation. All of my comments without excpetion are in favour of Pela , the clinicl progress and our companies future.
So a simple question why would people put out silly effort to edit, find fault in my every move?
As I have also said previously  I DONT CARE , what yoiu think of me.
I belive in ONC , Pelaroreps opportunity to help cancer patients.
Ironically, I recived a phone call from a 15+ yr freind of mine. We met at he gym & have come to know each other & our families.
he is 81 Does not own any stocks. Does howeverr have a decent portfolio under professional mangement.
Sadley his reason for phone call? while in hospital for a pain , is now under suspect, of all things Pancreatic Cancer.
So, needlass to say as a caring person, IM a bit upset.Unike a few who post nothing but attacks  . I m a caring person.
My friend Bill in in the throws of a 3rd check. So far one CT. MRI and now ASAP another CT.
This is all within the last week. I hope he does not have Panc cnacer. If he does Ill inform him about Pela.
No doubt being trial is not yet in progress he may miss out. Again I hope it does not even be a conversation we have.
Right now he is quite scared.That is important stuff not the daily price swings.
BTW other toipic, if anyone can discover how many Can  institutional holsings there are Id be happy to know.
The nas is easy to find. +/- 47/48 institutions about 1.75% of total.
That data is old however as posted as of Sept 2024.
The volume is anemic , why?
Year end tax loss is over. ONC(y) is a littel known junior biotech.
We follow way too close. Reality few know about it.
The plus side. many Drs invloved with the study do. 
What will come out of the 13th events? Could be anything or nothing. The presentation on the 25th however will be a game changer.
As far as I know, they said will be reporting on efficay on et a third co-therapy with Roche. 
That is an indisputable peiece of information availble on the most recent news release.
That was whenn I bought  more shares, posted on here & contrary to some mindless fools obsevations, the price went up.

Conclusion, Im tired and not well myself. Going for a rest.

Im in for the long haul, regardless of how liing that is,









Well said CF have a good weekend.
Fast:)
<< Previous
Bullboard Posts
Next >>